Evidence map›Paper›PMID 40598561›Full record

ArticleParasites & vectors2025

Simulium larvae susceptibility to temephos and the effect of 10 weeks of treatment of the Mbende tributary in the Nkam-Wouri River drainage of Cameroon on larval density and adult fly biting rates.

Raphael Awah Abong, Relindis Ekanya, Theobald Mue Nji, Fanny Fri Fombad, Glory N Amambo, Innocentia Ngong, Franck Noel Nietcho, Kebede Deribe, Benjamin Biholong, Flobert Njiokou and 4 more

Abstract read
In one paragraph

Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Raphael Awah AbongDepartment of Medical Laboratory Sciences, Faculty of Health Sciences, University of Buea, P.O. Box 63, Buea, Cameroon. abongr@gmail.com.
Relindis EkanyaResearch Foundation in Tropical Diseases and Environment, Buea, P.O. Box 474, Buea, Cameroon.
Theobald Mue NjiResearch Foundation in Tropical Diseases and Environment, Buea, P.O. Box 474, Buea, Cameroon.
Fanny Fri FombadResearch Foundation in Tropical Diseases and Environment, Buea, P.O. Box 474, Buea, Cameroon.
Glory N AmamboResearch Foundation in Tropical Diseases and Environment, Buea, P.O. Box 474, Buea, Cameroon.
Innocentia NgongResearch Foundation in Tropical Diseases and Environment, Buea, P.O. Box 474, Buea, Cameroon.
Franck Noel NietchoResearch Foundation in Tropical Diseases and Environment, Buea, P.O. Box 474, Buea, Cameroon.
Kebede DeribeSchool of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.
Benjamin BiholongDepartment of Disease Control, Epidemics and Pandemics, Ministry of Public Health, National Program for Onchocerciasis Control, Yaoundé, Cameroon.
Flobert NjiokouParasitology and Ecology Laboratory, Department of Animal Biology and Physiology, Faculty of Science, University of Yaoundé 1, P.O. Box 812, Yaoundé, Cameroon.
Same EkoboCentre for Research in Infectious Diseases (CRID), P.O. Box 13501, Yaoundé, Cameroon.
Charles WondjiCentre for Research in Infectious Diseases (CRID), P.O. Box 13501, Yaoundé, Cameroon.
Peter EnyongResearch Foundation in Tropical Diseases and Environment, Buea, P.O. Box 474, Buea, Cameroon.
Samuel WanjiResearch Foundation in Tropical Diseases and Environment, Buea, P.O. Box 474, Buea, Cameroon.

Funding

Research Networks for Health Innovations in sub-Saharan Africa Project processing number 66.3010.7-004.31
6 · The paper itself

Abstract

backgroundDespite over 18 years of annual ivermectin mass drug administration (MDA) in Cameroon's Nkam-Wouri River drainage, onchocerciasis transmission persists. Several reasons, including multiple breeding sites and abundant vector populations, contribute to ongoing transmission. High vector abundance also causes a biting nuisance to local populations. The change in paradigm from onchocerciasis control to elimination may not be achieved if alternative control measures are not used. There is a need to complement ivermectin MDA with other strategies. This study tested the susceptibility of Simulium larvae to temephos insecticide and monitored the effect of 10 weeks of ground larviciding on the larval density and black fly population.

methodsSimulium breeding sites along the course of three rivers within the Solle transmission zone in the Nkam-Wouri River drainage were identified. Seven temephos concentrations (0.001-0.1 mg/l) were tested on freshly collected Simulium larvae for susceptibility. Simulium biting rates were monitored using human landing catches before and during 10 weeks of ground larviciding. Fishing was used to assess the abundance and diversity of large aquatic fauna, while the presence and diversity of small invertebrate fauna were assessed during the collection of larvae, as they are usually found on the same substrates in the river. Ground larviciding was conducted using the spraying method at two dosing points.

resultsSix breeding sites were identified. Larval mortality decreased with temephos concentration, with 100% mortality observed at 0.1-0.025 mg/l. The non-target fauna included various fish species, crabs, crayfish, and small invertebrates. Ground larviciding cleared larvae from identified substrates and reduced adult fly biting rates by 82.8% (from 900 flies/man/day at the beginning to 180 flies/man/day at the end), a statistically significant decrease (χ

conclusionsSimulium larvae showed susceptibility to temephos. Clearance of larvae from traps and identified natural substrates, and a significant reduction in the Simulium biting rates were observed.

Indexed as

Insect Bites and StingsInsecticidesInsect VectorsSimuliidaeTemefosAnimalsCameroonHumansLarvaOnchocerciasisRiversInsecticidesTemefosBiting ratesLarval susceptibilityLarvicidingSimulium

Identifiers

PMID40598561
PMCPMC12210698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.